Device Trial Radar · NCT07585968
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
260
Planned (sponsor's estimate)
Start
Aug 17, 2026
Primary completion
Mar 2028
Study completion Sep 2028
Sponsor
- Lead sponsor
- Medtronic Cardiac Ablation SolutionsPublic (MDT)
- Sponsor type
- Industry
- First posted
- May 14, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Sphere VT is a prospective, multi-center, single-arm, unblinded pivotal clinical study. Adult subjects with recurrent, sustained, monomorphic ventricular tachycardia (MMVT) due to prior myocardial infarction (MI) will be enrolled and treated with the Sphere-9 Catheter and Affera Ablation System.
Conditions
- Ventricular Tachycardia
Interventions
Sphere-9 Catheter with the Affera Mapping and Ablation SystemDevice
Adult subjects with ventricular tachycardia will be enrolled and undergo ablation with the Sphere-9 Catheter with the Affera Mapping and Ablation System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary SafetyTime frame: As applicable, within 7 days or 3 months after the index ablation procedure
- Primary EffectivenessTime frame: Through 6 months after the index ablation procedure
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
South Denver Cardiology Associates
Littleton, Colorado · Active not recruiting
Ascension Saint Vincent Hospital - Indianapolis
Indianapolis, Indiana · Recruiting
Northwell Health Lenox Hill Hospital
Manhasset, New York · Recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.